Rectum Cancer Cases

Case 1: Rectum cancer

Name: Luis Peralta
Age: 61 years old
Country: Uruguay
Reason of consultation:
01/09/2002 He consults because of vegetant tumoration in lower rectum.
Personal antecedents:
No personal antecedents to remark.
Family antecedents:
None to remark.
Present disease antecedents:
Diarrheic depositions since a year ago with comes and goes. Since 12/30/2001 presents recto-rraghia. He has a PAI done and does not present any lesion. In a rectum tactum it is detected tumoration in back and lateral side of rectum, movable, of 30 mm approximately. The CCV shows vegetant tumoration of lower rectum that infiltrates circumferentially the wall 10 cm. Away from the anus limit. The anatomy pathology result is expected.
On 01/09/2002 begins with the medicament at the dosage of 40 drops 4 times per day sublingually.
Disease evolution:
02/01/2002: Presents well differentiated adeno-carcinoma, infiltrative, of lower rectum. A front low resection is performed plus TCT plus Chemotherapy. A relative of his comes with data and clinical register, we indicate increase the medicament dosage to 50 drops 4 times per day sublingually.
07/24/2002: The patient comes to consult in good general state. He presents surgery scar without particularities. The abdomen is soft, depressible and painless, no viscero-megalies are palpable. He finished with concomitant radiotherapy and chemotherapy. Intestinal transit conserved. Professor Torres will see him in a month time. 30 drops 4 times per day are recommended. A control is requested in a month and a half time. Hyperproteic diet.
08/14/2002: The patient comes to consult and is stable, in hospital oncology control. He goes on with 30 drops 4 times per day sublingually.
At the present moment, in clinic cure, on release, with a maintenance dosage of the medicament.
Conclusions:

It is about a patient of 61 years old proceeding from Uruguay, with an infiltrative well differentiated lower rectum adeno-carcinoma, he underwent a low front resection plus telecobalto-therapy plus chemotherapy.
On 01/09/2002: begins with the medicament at a dosage of 40 drops, 4 times per day sublingually, which afterwards is increased to 50 drops 4 times per day.
He achieves total improvement and we can see GREEN SAP action in a well differentiated lower rectum adeno-carcinoma.
With no doubt GREEN SAP with its action contributed to the no appearance of metastases and the clinic cure of the patient, who also was treated with conventional therapy, what shows GREEN SAP innocuousness, the high tolerance to it and the lack of collateral effects which led to the patient’s clinic cure. Remarking it is not a clinic cure up to 5 years from now on, as we stated at the beginning of this work, but the expression of the excellent state of health that the patient has at the present moment.
In this patient GREEN SAP action is of no doubt. The experience we have indicates us that in his pathology, is a medicament of first level, achieving complete remissions and a life status, so important in these patients, very superior, reason why there is no doubt for us that GREEN SAP has achieved to revert and control the oncology disease avoiding the dissemination as this work team’s experience throughout the years we worked with this medicament has seen